UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.387

Sortiert nach

Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma

PloS one, 2017-07, Vol.12 (7), p.e0181097-e0181097

2017

Link zum Volltext

Verfügbarkeit prüfen

Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non‐hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab

British journal of haematology, 2019-01, Vol.184 (2), p.223-231

2019

Link zum Volltext

Verfügbarkeit prüfen

Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination

Science advances, 2022-07, Vol.8 (28), p.eabm7201-eabm7201

2022

Link zum Volltext

Verfügbarkeit prüfen

NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients

The Journal of immunology (1950), 2016-08, Vol.197 (3), p.795-806

2016

Link zum Volltext

Verfügbarkeit prüfen

AKT activity orchestrates marginal zone B cell development in mice and humans

Cell reports (Cambridge), 2023-04, Vol.42 (4), p.112378-112378, Article 112378

2023

Link zum Volltext

Verfügbarkeit prüfen

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

Journal of clinical medicine, 2022-12, Vol.11 (23), p.7162

2022

Link zum Volltext

Verfügbarkeit prüfen

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients

Mayo Clinic proceedings, 2015-06, Vol.90 (6), p.756-764

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma

British journal of haematology, 2013-01, Vol.160 (2), p.207-215

2013

Link zum Volltext

Verfügbarkeit prüfen

Conditionality and Control: Its implications for groups on welfare and some particular issues for Indigenous people and women

Social alternatives, 2020-01, Vol.39 (1), p.54-59

Cox, Eva Maria

2020

Link zum Volltext

Verfügbarkeit prüfen

Refining a model of collaborative care for people with a diagnosis of bipolar, schizophrenia or other psychoses in England: a qualitative formative evaluation

BMC psychiatry, 2019-01, Vol.19 (1), p.7-7, Article 7

2019

Link zum Volltext

Verfügbarkeit prüfen

Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review

Cancers, 2023-09, Vol.15 (18), p.4440

2023

Link zum Volltext

Verfügbarkeit prüfen

Exercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of care

Leukemia & lymphoma, 2021-02, Vol.62 (3), p.560-570

2021

Link zum Volltext

Verfügbarkeit prüfen

Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?

Radiation oncology (London, England), 2012-08, Vol.7 (1), p.129-129, Article 129

2012

Link zum Volltext

Verfügbarkeit prüfen

Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds

Cancer letters, 2022-01, Vol.524, p.144-150

2022

Link zum Volltext

Verfügbarkeit prüfen

Relapsing Long-Lasting Garcin Syndrome Revealing Skull Base Diffuse B Cell Lymphoma: The Diagnosis through the “Hartel's Route”

Journal of neurological surgery. Part B, Skull base, 2019-02, Vol.80 (1), p.105-108

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's disease

Frontiers in oncology, 2023-04, Vol.13, p.1059393-1059393

2023

Link zum Volltext

Verfügbarkeit prüfen

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

Haematologica (Roma), 2014-01, Vol.99 (1), p.125-130

2014

Link zum Volltext

Verfügbarkeit prüfen

Feminism, gender, and power relations in policy: Starting a new conversation

Australian journal of public administration, 2018-12, Vol.77 (4), p.519-524

2018

Link zum Volltext

Verfügbarkeit prüfen

Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules

Cancer letters, 2024-06, Vol.591, p.216900-216900, Article 216900

2024

Link zum Volltext

Verfügbarkeit prüfen

Very long‐lasting remission of refractory T‐large granular lymphocytes leukemia and myeloma by lenalidomide treatment

European journal of haematology, 2013-08, Vol.91 (2), p.183-186

2013

Link zum Volltext

Verfügbarkeit prüfen

Lenalidomide for aggressive B‐cell lymphoma involving the central nervous system?

American journal of hematology, 2011-11, Vol.86 (11), p.957-957

2011

Link zum Volltext

Verfügbarkeit prüfen

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)

Blood, 2003-03, Vol.101 (6), p.2125-2131

2003

Link zum Volltext

Verfügbarkeit prüfen

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162

Journal of clinical medicine, 2023-11, Vol.12 (22), p.7053

2023

Link zum Volltext

Verfügbarkeit prüfen

Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma Not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Review of the Literature

Diagnostics (Basel), 2020-05, Vol.10 (6), p.341

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.387

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.191)
Mit Volltextzugriff
(1.245)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(866)
Life Sciences & Biomedicine
(761)
Humans
(622)
Female
(349)
Male
(331)
Adult
(221)
Middle Aged
(193)
Aged
(165)
Animals
(159)
Biological And Medical Sciences
(156)
Medical Sciences
(121)
Oncology
(104)
Adolescent
(101)
Immunology
(101)
Infectious Diseases
(97)
Young Adult
(85)
Mice
(79)
Risk Factors
(79)
Science & Technology - Other Topics
(78)
Microbiology
(73)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(50)
Plos One
(30)
Nature Communications
(15)
The Journal Of Infectious Diseases
(13)
Vaccine
(13)
International Journal Of Radiation Oncology, Biology, Physics
(12)
Journal Of Clinical Oncology
(12)
Leukemia & Lymphoma
(12)
Nature
(12)
British Journal Of Haematology
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma

Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non‐hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab

Time to progression of mantle cell lymphoma after high‐dose cytarabine‐based regimens defines patients risk for death

Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination

NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients

AKT activity orchestrates marginal zone B cell development in mice and humans

Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients

Efficacy and safety of bendamustine for the treatment of patients with recurring Hodgkin lymphoma

Conditionality and Control: Its implications for groups on welfare and some particular issues for Indigenous people and women

Refining a model of collaborative care for people with a diagnosis of bipolar, schizophrenia or other psychoses in England: a qualitative formative evaluation

Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review

Exercise training (ET) in adult and elderly patients receiving anti-lymphoma treatments is feasible and may improve the provision of care

Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?

Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds

Relapsing Long-Lasting Garcin Syndrome Revealing Skull Base Diffuse B Cell Lymphoma: The Diagnosis through the “Hartel's Route”

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's disease

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

Feminism, gender, and power relations in policy: Starting a new conversation

Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedules

Very long‐lasting remission of refractory T‐large granular lymphocytes leukemia and myeloma by lenalidomide treatment

Lenalidomide for aggressive B‐cell lymphoma involving the central nervous system?

Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162

Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma Not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Review of the Literature

Suchergebnisse filtern